{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:10:00Z","timestamp":1753877400536,"version":"3.41.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Autoimmune diseases are caused by the misdirection of the immune system as the side effect of antibody diversity, wherein each B cell possesses unique characteristics defined by its antibodies. To address this issue, I have developed several cell surface immunoglobulin (Ig)-aimed immune memory erasers (IgAim) that consist of toxins explicitly targeted to cell surface Ig (sIg) on B cells. IgAim is created by replacing the receptor binding domain of diphtheria toxin with Staphylococcal protein A (SpA), affibodies, or specific antigens. The toxins IgAimG and IgAimA selectively killed sIgG+ and sIgA+ B cells, respectively. Treatment with these proteins kills between 90% and 99% of the target cell population without displaying toxicity toward other classes of B cells or nontarget cell types. The specificity of IgAim is highlighted by IgAimP7 which exclusively kills B cells expressing an antibody against pollen allergen Phleum pratense (Phl) p7. IgAim could be the basis of an effective future family of therapeutic agents for treating autoimmune diseases as well as B leukemia.<\/jats:p>","DOI":"10.1093\/narmme\/ugaf016","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:32:00Z","timestamp":1746070320000},"source":"Crossref","is-referenced-by-count":0,"title":["IgAim: cell surface Ig-aimed immune memory erasers for the therapy of autoimmune diseases and B leukemia"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-4549","authenticated-orcid":false,"given":"Hiroshi","family":"Arakawa","sequence":"first","affiliation":[{"name":"IFOM ETS - The AIRC Institute of Molecular Oncology , 20139\u00a0 Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"2025051306262057200_B1","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2025051306262057200_B2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.1067308","article-title":"Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion","volume":"295","author":"Arakawa","year":"2002","journal-title":"Science"},{"key":"2025051306262057200_B3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"2025051306262057200_B4","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3389\/fmicb.2019.02340","article-title":"Targeted diphtheria toxin-based therapy: a review article","volume":"10","author":"Shafiee","year":"2019","journal-title":"Front Microbiol"},{"key":"2025051306262057200_B5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/90795","article-title":"Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice","volume":"19","author":"Saito","year":"2001","journal-title":"Nat Biotechnol"},{"key":"2025051306262057200_B6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/bab.1742","article-title":"A comprehensive review on staphylococcal protein A (SpA): its production and applications","volume":"66","author":"Rigi","year":"2019","journal-title":"Biotech App Biochem"},{"key":"2025051306262057200_B7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/359752a0","article-title":"Crystal structure of a streptococcal protein G domain bound to an Fab fragment","volume":"359","author":"Derrick","year":"1992","journal-title":"Nature"},{"key":"2025051306262057200_B8","doi-asserted-by":"publisher","first-page":"17446","DOI":"10.1016\/S0021-9258(19)47393-6","article-title":"Entry of diphtheria toxin-protein A chimeras into cells","volume":"266","author":"Madshus","year":"1991","journal-title":"J Biol Chem"},{"key":"2025051306262057200_B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2007.01.008","article-title":"Antibody internalization studied using a novel IgG binding toxin fusion","volume":"321","author":"Mazor","year":"2007","journal-title":"J Immunol Methods"},{"key":"2025051306262057200_B10","doi-asserted-by":"publisher","first-page":"e0194887","DOI":"10.1371\/journal.pone.0194887","article-title":"Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system","volume":"13","author":"Szczesny","year":"2018","journal-title":"PLoS One"},{"key":"2025051306262057200_B11","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1128\/AEM.65.9.4134-4140.1999","article-title":"Staphylococcal surface display of immunoglobulin A (IgA)- and IgE-specific in vitro-selected binding proteins (affibodies) based on Staphylococcus aureus protein A","volume":"65","author":"Gunneriusson","year":"1999","journal-title":"Appl Environ Microb"},{"key":"2025051306262057200_B12","doi-asserted-by":"publisher","first-page":"e1600699","DOI":"10.1126\/sciadv.1600699","article-title":"A method to convert mRNA into a gRNA library for CRISPR\/Cas9 editing of any organism","volume":"2","author":"Arakawa","year":"2016","journal-title":"Sci Adv"},{"key":"2025051306262057200_B13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025051306262057200_B14","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1371\/journal.pbio.0040200","article-title":"B cell antigen receptor signaling and internalization are mutually exclusive events","volume":"4","author":"Hou","year":"2006","journal-title":"PLoS Biol"},{"key":"2025051306262057200_B15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nbt0897-772","article-title":"Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain","volume":"15","author":"Nord","year":"1997","journal-title":"Nat Biotechnol"},{"key":"2025051306262057200_B16","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1038\/srep05885","article-title":"A tool kit for rapid cloning and expression of recombinant antibodies","volume":"4","author":"Dodev","year":"2014","journal-title":"Sci Rep"},{"key":"2025051306262057200_B17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1096\/fasebj.13.8.843","article-title":"Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7","volume":"13","author":"Niederberger","year":"1999","journal-title":"FASEB j"},{"key":"2025051306262057200_B18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","article-title":"Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells","volume":"7","author":"Chng","year":"2015","journal-title":"mAbs"},{"key":"2025051306262057200_B19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature22353","article-title":"The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3\u03b2 inhibition","volume":"546","author":"Varano","year":"2017","journal-title":"Nature"},{"key":"2025051306262057200_B20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41587-020-0577-1","article-title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures","volume":"38","author":"Eroshenko","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025051306262057200_B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: a comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J Autoimmun"},{"key":"2025051306262057200_B22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"2025051306262057200_B23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","article-title":"Affibody molecules in biotechnological and medical applications","volume":"35","author":"St\u00e5hl","year":"2017","journal-title":"Trends Biotechnol"}],"container-title":["NAR Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/narmolmed\/advance-article-pdf\/doi\/10.1093\/narmme\/ugaf016\/63037443\/ugaf016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/2\/2\/ugaf016\/63037443\/ugaf016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/2\/2\/ugaf016\/63037443\/ugaf016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T10:26:31Z","timestamp":1747131991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/narmolmed\/article\/doi\/10.1093\/narmme\/ugaf016\/8123394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,29]]}},"URL":"https:\/\/doi.org\/10.1093\/narmme\/ugaf016","relation":{},"ISSN":["2976-856X"],"issn-type":[{"type":"electronic","value":"2976-856X"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,29]]},"article-number":"ugaf016"}}